|
 |
TorsemideThis page contains recent news articles, when available, and an overview of Torsemide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Torsemide (when available) Torsemide, a monosulfonamyl loop diuretic, differs form other thiazide diuretics in that a double ring system is incorporated into its structure. Torsemide is used alone or with atenolol in the management of hypertension and edema. It inhibits reabsorption of sodium and chloride in the luminal membrane of the ascending limb of the loop of Henle by interfering with the chloride binding site of the 1Na+, 1K+, 2Cl-; cotransport system. This increases the rate of delivery of tubular fluid and electrolytes to the distal sites of hydrogen and potassium ion secretion, while plasma volume contraction increases aldosterone production. The increased delivery and high aldosterone levels promote sodium reabsorption at the distal tubules, thus increasing the loss of potassium and hydrogen ions. Torsemide's effects in other portions of the nephron have not been demonstrated. Antihypertensive - Diuretics lower blood pressure initially by reducing plasma and extracellular fluid volume; cardiac output also decreases. Eventually, cardiac output returns to normal with an accompanying decrease in peripheral resistance. For the treatment of hypertension, edema induced by congestive heart failure or renal disease and ascites assocated with hepatic disease Mechanism Of Action: Torasemide acts on the Na+/K+/2Cl- co-transporter. Torsemide inhibits sodium ion transport across the renal tubular epithelium in the cortical diluting segment of the ascending limb of the loop of Henle. By increasing the delivery of sodium to the distal renal tubule, Torsemide indirectly increases potassium excretion via the sodium-potassium exchange mechanism. News Articles on Torsemide India Sun Pharma gets FDA nod for torsemide tablets - Feb 27, 2008 MUMBAI, Feb 28 (Reuters) - Sun Pharmaceutical Industries Ltd (SUN.BO) has received approval from the US Food and Drug Administration for torsemide tablets ... Reuters Torsemide (Systemic). - Jul 28, 2005 Torsemide (TORE-se-mide ) belongs to the group of medicines called loop diuretics. Torsemide is given to help reduce the amount of water in the body in ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Q3 2006 Penwest Pharmaceuticals Earnings Conference Call - Final. - Oct 31, 2006 Torsemide ER is a product we are developing for the once a day treatment of edema ... Torsemide is a loop diuretic that is currently only available in an ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com BROWN TORSEMIDE APPEAL DENIED - Jul 14, 2007 The Ontario Racing Commission has denied the appeal of trainer Roger Brown, who had received a 180-day suspension and $5000 fine for a positive test for the ... Harnesslink Trainer used diuretic 'in good faith' - Feb 21, 2007 Anyone found guilty by the ORC of administering torsemide faces a minimum 60-day suspension. Mitchell said diuretics are Class 3 (with Class 1 being the ... SLAM! Sports Penwest Reports Fourth Quarter and Year End 2005 Financial Results. - Mar 2, 2006 I am particularly pleased with the positive clinical data on both our torsemide ER and nalbuphine ER products. We remain focused on building our portfolio ... Free with registration - PR Newswire - AccessMyLibrary.com Racing to clean up image - Feb 20, 2007 The torsemide positives came from five Ontario tracks including Woodbine and London's Western Fair Raceway. Finally, over the past six months, ... SLAM! Sports Q2 2006 Penwest Pharmaceuticals Earnings Conference Call - Part 1. - Jul 26, 2006 ...sell products for which the Company receives royalties; regulatory risks relating to drugs in development such as torsemide ER and nalbuphine ER, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Press Release: Penwest Announces Results of Phase IIa Trial for … - Dec 20, 2005 Torsemide ER Indicates Better Sodium Excretion in Congestive Heart Failure Patients ... Torsemide ER, a controlled-release formulation of torsemide that was ... Pay-Per-View - PR Newswire - HighBeam Research Penwest Announces Results of Phase IIa Trial for PW2132 - Dec 20, 2005 Torsemide ER, a controlled-release formulation of torsemide that was developed using ... Torsemide is currently given as an immediate release oral tablet. ... biotech-intelligence.com Sun gets US FDA nod - Apr 15, 2008 These generic torsemide tablets are therapeutic equivalents of Roche's ... These strengths of torsemide tablets have annual sales of approximately $35 ... Express Pharma Press Release: Penwest Begins Next Study in Development of … - Jan 19, 2007 Operating Officer of Penwest, said, "In 2005 ... torsemide ER and nalbuphine ER products. ... Phase I studies for nalbuphine ER and torsemide ER, and . ... Pay-Per-View - PR Newswire - HighBeam Research Q3 2006 Penwest Pharmaceuticals Earnings Conference Call - Part 1. - Oct 3, 2006 Torsemide ER is a product we are developing for the once a day treatment of edema ... Torsemide is a loop diuretic that is currently only available in an ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com DR. PAUL DONOHUE GOOD HEALTH - Jun 12, 2005 My doctor gave me a prescription for torsemide. ... I read a book that said loop diuretics like torsemide could cause gout attacks. Is all this due to gout? ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Quick Study - May 13, 2008 THIS STUDY analyzed data on 3269 men (average age, 73); 265 of them took loop diuretics -- either furosemide (Lasix), bumetanide (Bumex) or torsemide ... Pay-Per-View - Washington Post - ProQuest Archiver REASONS FOR COMMISSION RULINGS - May 26, 2007 Preszcator had been issued a $1500 fine and a 60-day suspension for the positive Torsemide test on the horse Simply Marvellous. As a result of Preszcator's ... Harnesslink Company Profile Report - Sep 13, 2008 Demadex (Torsemide). Stroke. Anticoagulating Agents (Anticoagulants) ... Bumex (Bumetanide); Demadex (Torsemide). Hepatitis. Hepatitis B. Chronic ... $50.00 - Revere Reports - Revere DIURETIC, LOOP (Oral route, Injection route, Intravenous route).(Drug... - May 1, 2007 Furosemide and torsemide are also used to treat high blood pressure ... Anuric (inability to urinate) -- Torsemide should NOT be used if you have this ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com United States 5th Circuit Court of Appeals Reports - HUDSON v. TEXAS ... - Jul 10, 2006 A post-race urine sample obtained from St. Martin's Cloak tested positive for Torsemide, a prohibited drug. A split sample analyzed by Louisiana State ... Pay-Per-View - United States 5th Circuit Court of... - Loislaw Treatment of edema. - Jun 1, 2005 Absorption of bumetanide and torsemide is more complete, ranging from 80 to 100 percent. (6) Thiazide diuretics, such as chlorothiazide (Diuril) and ... $4.95 - American Family Physician - ECNext Competitors by Product Report - Sep 13, 2008 Barr Pharmaceuticals, Inc. (BRL) Products:. Torsemide ... Par Pharmaceutical Companies, Inc. (PRX) Products:. Torsemide ... $75.00 - Revere Reports - Revere Penwest Reports Fourth Quarter and Year End 2006 Financial Results. - Feb 28, 2007 This increase was primarily due to increased spending on the development of torsemide ER, a compound we are developing for edema, and on other early-stage ... $4.95 - PR Newswire - ECNext Heart health: ask Dr. Zipes: a noted cardiologist answers your... - Mar 1, 2007 Now I'm taking Torsemide instead of Lasix. Foods taste a little better, ... I assume it is still better while you are taking the Torsemide. ... Pay-Per-View - Saturday Evening Post - HighBeam Research Heart health: ask Dr. Zipes: a noted cardiologist answers your... - Mar 1, 2007 Now I'm taking Torsemide instead of Lasix. Foods taste a little better, ... I assume it is still better while you are taking the Torsemide. ... $4.95 - Saturday Evening Post - ECNext Q2 2006 Penwest Pharmaceuticals Earnings Conference Call - Part 2. - Jul 26, 2006 I wanted to go back to torsemide and nalbuphine and the optimization of the formulations there. It does look like you're taking your time starting to study ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Interindividual Variation in the Pharmacokinetics of 9- … - May 18, 2008 Genetic variation at the CYP2C locus and its association with torsemide biotransformation. Pharmacogenomics J. 7, 200–211 (2007). ... Nature.com New generics. - Apr 4, 2005 Torsemide tablets, in 5-, 10-, and 20-mg strengths, are available from Roxane Laboratories, Columbus, Ohio, (614) 272-4774. Roxane is a subsidiary of ... $9.94 - Drug Topics - Alacra Store Roxane Laboratories. - May 2, 2005 Roxane Laboratories received final FDA approval for torsemide tablets in 5 mg, ... Torsemide tablets are the AB-rated equivalent of Roche Pharmaceuticals' ... $9.94 - Drug Store News - Alacra Store Merger and Acquisition Scenario - Nov 25, 2006 Procardia XL (Nifedipine); PW2132 (Torsemide ER); PW2101; PW4102 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension ... $250.00 - Revere Reports - Revere Competitors by Product Report - Apr 5, 2008 Par Pharmaceutical Companies, Inc. (PRX) Products:. Torsemide. Roche Holding Ltd. (ADR) (RHHBY) Products:. Bumex (Bumetanide); Demadex (Torsemide) ... $75.00 - Revere Reports - Revere ORC RELEASES CLASS III POSITIVES - Mar 15, 2007 The Ontario Racing Commission has fined and suspended eight trainers for a total of 10 positive tests for the Class III drug Torsemide. ... Harnesslink Company Profile Report - Dec 20, 2008 Products:. Torsemide. Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents ... Torsemide. Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents ... $50.00 - Revere Reports - Revere PRESZCATOR & HOUGHTON RULINGS - May 8, 2007 On March 30, 2007, Preszcator had been issued a $1500 fine and a 60-day suspension after a positive test for the Class 3 drug Torsemide. ... Harnesslink Furosemide Resistance in Heart Failure Patients - Aug 3, 2007 The authors concluded that torsemide is equivalent to furosemide in the treatment of refractory CHF. The results of these pilot studies offer clinicians a ... Medscape ORC REPORTS 20 POSITIVES - Feb 17, 2007 The positive tests for the banned substance torsemide were reported during this period, and involved 15 ... Torsemide, a diuretic, is a Class III drug. ... Harnesslink Penwest Awaits FDA Decision - Jun 21, 2006 ...“In addition to watching Endo's rollout, we hope to see Penwest advance its pipeline programs for Nalbuphine ER, another product for pain, and Torsemide ER, ... Forbes Right-Sided Heart Failure - Symptoms, Diagnosis, Treatment of Right- … - Sep 23, 2008 Furosemide, torsemide, or bumetanide can help moderate to severe symptoms. Hydrochlorothiazide, chlorthalidone, and chlorothiazide may be used for mild ... New York Times Article: Tentative OK(Teva Pharmaceutical Industries Ltd. gets... - Aug 29, 2005 Article: Teva to offer torsemide. (Marketplace).(Teva ... ... The FDA has approved Teva Pharmaceutical Industries Ltd.'s torsemide tablets for treatment of ... Pay-Per-View - Chain Drug Review - HighBeam Research Hypertension Classes of Medications - Hypertension Health Information... - Jul 15, 2008 Loop diuretics include bumetanide (Bumex), furosemide (Lasix), ethacrynic acid (Edecrin), and torsemide (Demadex). Loop and thiazide diuretics reduce the ... New York Times Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... Target Products:. PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Chan. $250.00 - Revere Reports - Revere Teva introduces glimepiride tablets.(Teva Pharmaceuticals USA Inc.)( … - Nov 21, 2005 Article: Teva's torsemide. (RXs).(Teva Pharmaceuticals ... ... Teva Pharmaceuticals USA has introduced torsemide tablets in four strengths. ... Pay-Per-View - Chain Drug Review - HighBeam Research Teva profits double.(Generic Drugs)(Teva Pharmaceutical Industries... - Nov 20, 2006 Article: Teva to offer torsemide. (Marketplace).(Teva ... ... The FDA has approved Teva Pharmaceutical Industries Ltd.'s torsemide tablets for treatment of ... Pay-Per-View - Chain Drug Review - HighBeam Research Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 29, 2007 Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 15, 2007 Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 8, 2007 Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153. Target. ANGPTL4 Antibodies; LX-1031 ... PW2132 (Torsemide ER). Research/Preclinical Stage Products ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Research/Preclinical Stage Products ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 12, 2007 Target. Procardia XL (Nifedipine); PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 13, 2007 Target. Nifedipine XL; PW2132 (Torsemide ER); PW4110; PW4153 ... PW2132 (Torsemide ER). Vascular Disorders. Hypertension. Calcium Channel Blocking Agents ... $250.00 - Revere Reports - Revere Judge backs Teva exclusivity claim.(Teva Pharmaceutical Industries... - Nov 21, 2005 Article: Teva to offer torsemide. (Marketplace).(Teva ... ... The FDA has approved Teva Pharmaceutical Industries Ltd.'s torsemide tablets for treatment of ... Pay-Per-View - Chain Drug Review - HighBeam Research Article: Camber choices.(Newsmakers)(Camber Pharmaceuticals Inc. … - Jan 21, 2008 Article: Camber launches torsemide tablets.(RX/Generic ... Chain Drug Review; September 28, 2009 ; 572 words ...[ILLUSTRATION OMITTED] PISCATAWAY ... Pay-Per-View - Chain Drug Review - HighBeam Research Teva gets approval in EU.(RX RETAIL PHARMACY: Generic Drugs)(Teva … - Jan 21, 2008 Article: Teva to offer torsemide. (Marketplace).(Teva ... ... The FDA has approved Teva Pharmaceutical Industries Ltd.'s torsemide tablets for treatment of ... Pay-Per-View - Chain Drug Review - HighBeam Research Teva Pharmaceuticals.(RX/GENERIC DRUGS--Profiles)(Teva … - Sep 29, 2008 Article: Teva's torsemide. (RXs).(Teva Pharmaceuticals USA ... ... Teva Pharmaceuticals USA has introduced torsemide tablets in four strengths. ... Pay-Per-View - Chain Drug Review - HighBeam Research Teva, UCB team up.(RX: RETAIL PHARMACY)(Teva Pharmaceutical … - Feb 4, 2008 Article: Teva to offer torsemide. (Marketplace).(Teva ... ... The FDA has approved Teva Pharmaceutical Industries Ltd.'s torsemide tablets for treatment of ... Pay-Per-View - Chain Drug Review - HighBeam Research Quick Study | Article from The Washington Post | HighBeam Research - May 13, 2008 THIS STUDY analyzed data on 3269 men (average age, 73); 265 of them took loop diuretics -- either furosemide (Lasix), bumetanide (Bumex) or torsemide ... Pay-Per-View - Washington Post - HighBeam Research Penwest Announces That Endo Reports Receiving Final FDA Approval … - Jun 24, 2006 ...among other things, sell products for which the Company receives royalties; regulatory risks relating to drugs in development such as, torsemide ER, ... Medical News Today - Medical News Today (press release) Teva to appeal ruling.(Generic Drugs)(Teva Pharmaceutical Industries... - Apr 23, 2007 Article: Teva to offer torsemide. (Marketplace).(Teva ... ... The FDA has approved Teva Pharmaceutical Industries Ltd.'s torsemide tablets for treatment of ... Pay-Per-View - Chain Drug Review - HighBeam Research Article: Camber Pharmaceuticals Inc.(RX/GENERIC DRUGS--Profiles)( … - Sep 17, 2007 Article: Camber launches torsemide tablets.(RX/Generic ... Chain Drug Review; September 28, 2009 ; 572 words ...[ILLUSTRATION OMITTED] PISCATAWAY ... Pay-Per-View - Chain Drug Review - HighBeam Research Teva Pharmaceuticals.(RX/GENERIC DRUGS--Profiles)(Company … - Sep 17, 2007 Article: Teva's torsemide. (RXs).(Teva Pharmaceuticals USA ... ... Teva Pharmaceuticals USA has introduced torsemide tablets in four strengths. ... Pay-Per-View - Chain Drug Review - HighBeam Research Drug scandal grips Ontario - Feb 26, 2007 That followed 20 positive tests at five Ontario tracks in late January and early February for the banned diuretic torsemide. ... Canada.com Increased Serum Creatinine More Likely when Nesiritide is Combined … - Nov 16, 2005 High-dose diuretic use was defined as a maximum daily dose of furosemide 160 mg or greater, bumetanide 4 mg or greater, torsemide 80 mg or greater, ... DG News Penwest Names Dr. Amy O'Donnell Senior Director, Clinical Development... - Oct 5, 2006 ...regulatory risks relating to drugs in development such as, torsemide ER and nalbuphine ER, including the timing and outcome of regulatory action; ... Free with registration - PR Newswire - AccessMyLibrary.com Drug dosing adjustments in patients with chronic kidney disease.(Drug... - May 15, 2007 25 to 50 mg daily Torsemide (Demadex) (5) No adjustment needed Triamterene ... 24 hours Thiazides ([parallel]) 100% 100% Avoid Torsemide (Demadex) (5) ... $4.95 - American Family Physician - ECNext Classes of Medications - Apr 14, 2006 ...diuretics it is important to avoid dehydration and potassium loss. Loop diuretics include bumetanide (Bumex), furosemide (Lasix), and torsemide (Demadex). HealthCentral.com QUICK STUDY - May 27, 2008 This study analyzed data on 3269 men (average age, 73); 265 of them took loop diuretics -- either furosemide (Lasix), bumetanide (Bumex) or torsemide ... $2.95 - Miami Herald - NewsBank Can high BP worsen hyperglycemia? - Dec 29, 2006 Another reasonable alternative is to use a loop diuretic (eg, furosemide or torsemide) since the shorter duration of action reduces the effect on potassium ... Cortlandt Forum Manufacturers get FDA approval on broad range of treatments. - Mar 28, 2005 Roxane Laboratories Inc. It has received approval of torsemide tablets in 5-, 10- and 20-mg strengths. The product is AB-rated to Demadex. ... $9.94 - Chain Drug Review - Alacra Store American ginseng. - Aug 1, 2006 Water pills (diuretics, examples: furosemide (Lasix(R), torsemide (Demadex(R), bumetanide (Bumex(R)). Medicines for your heart (digitalis, examples: digoxin ... Free with registration - AltCareDex Alternative Medicines - AccessMyLibrary.com Global top 200 generic drugs by retail sales in dollars and percent … - Feb 21, 2005 63690 3.6 114 Nitrofurantoin Mcroc 62745 9.5 115 Clorazepate Dipot 62354 -19.2 116 Diltiazem SR 61326 -0.3 117 Torsemide 61207 -13.1 118 Methylphenidate ... $20.00 - Drug Topics - Alacra Store Role of active surveillance in improving hospital adverse drug event ... - Sep 1, 2006 Three newly marketed drugs, ie the diuretic, torsemide; the vasodilator, cilostazol; and the antihyperlipidemic, rosuvastatin, were randomly selected for ... Free with registration - Indian Journal of Pharmacology - AccessMyLibrary.com David P. Meeker, MD Named to Penwest Pharmaceuticals Board Of … - Jan 4, 2007 ...regulatory risks relating to drugs in development such as torsemide ER and nalbuphine ER, including the timing and outcome of regulatory action; ... RedOrbit Update! Gemini Explorations Inc. Sampling Program -- Los Chorros Gold... - Oct 4, 2007 The company's product candidates in clinical development include Nalbuphine ER for the treatment of moderate chronic pain; and Torsemide ER for the ... Free with registration - M2 Presswire - AccessMyLibrary.com PRB, FREE, ICOP, NURO, PPCO, TASR Have Been Added To Naked … - Jun 6, 2007 The company's product candidates in clinical development include Nalbuphine ER for the treatment of moderate chronic pain; and Torsemide ER for the ... Free with registration - M2 Presswire - AccessMyLibrary.com THREE MORE CLASS III POSITIVES - Mar 17, 2007 On February 16 the ORC announced a detailed investigation into 20 positive tests for Torsemide at Ontario racetracks. Trot Insider contacted the ORC but ... Harnesslink Germanium. - Feb 1, 2007 Water pills (examples: furosemide (Lasix(R)), torsemide (Demadex(R))) Warnings: * Before taking Germanium, tell your doctor if you are pregnant or ... Free with registration - AltCareDex Alternative Medicines - AccessMyLibrary.com Sun Gets FDA Tentative OK for Generic Gemzar - Mar 14, 2008 ...comes roughly a week after Sun announced it had received final FDA approval for its ANDA to market a generic version of Roche's Demadex (torsemide), ... FDA news - FDA news (subscription) Penwest to Present at the 2006 BIO Investor Forum. - Oct 10, 2006 ...regulatory risks relating to drugs in development such as, torsemide ER and nalbuphine ER, including the timing and outcome of regulatory action; ... Free with registration - PR Newswire - AccessMyLibrary.com ORC DIRECTIVE ON STAYS - Apr 18, 2007 Furthermore, trainers Wayne Prezscator and Paul Walter have been issued stays by the ORC pending their appeal hearings for Class III positives (Torsemide). ... Harnesslink Clinical trials update: December 2005. - Jan 16, 2006 2 Endogenous peptide Biosciences ligand of the CRF-R2 Inc. (NBIX) receptor Penwest PW2132 Extended-release Pharmaceuticals formulation of torsemide Co. ... Free with registration - Bioworld Financial Watch - AccessMyLibrary.com Penwest to Present at 2006 UBS Global Life Sciences Conference. - Sep 15, 2006 ...regulatory risks relating to drugs in development such as, torsemide ER and nalbuphine ER, including the timing and outcome of regulatory action; ... Free with registration - PR Newswire - AccessMyLibrary.com Penwest Names Benjamin Palleiko Senior Vice President, Corporate … - Jun 19, 2006 ...among other things, sell products for which the Company receives royalties; regulatory risks relating to drugs in development such as, torsemide ER, ... Free with registration - PR Newswire - AccessMyLibrary.com MNTA, PPCO, USEG, WFII, ARGA, DORB Have Also Been Removed … - Jun 15, 2007 The company's product candidates in clinical development include Nalbuphine ER for the treatment of moderate chronic pain; and Torsemide ER for the ... Free with registration - M2 Presswire - AccessMyLibrary.com Electrochemistry; Electrochemical characterization of the human … - Jul 8, 2005 In contrast, torsemide, carbon monoxide and oxygen led to an anodic shift in redox potential." "These results suggest alternative mechanisms by which ... Pay-Per-View - Drug Week - Factiva, from Dow Jones United States top 200 generic drugs by retail sales in dollars for... - Feb 28, 2005 62354 122 Diltiazem SR 61326 123 Torsemide 61207 124 Methylphenidate 60249 125 Metronidazole tabs 59997 126 Triamcinlon acet. top. ... $20.00 - Chain Drug Review - Alacra Store Generics makers keep new products coming.(RX/GENERICS)(Statistical … - Sep 17, 2007 Meloxicam $37291237.31 Greenstone Ltd. Glipizide XL $37283358.48 Watson Labs Lisinopril/HCTZ $36958887.91 Teva USA Torsemide $36828437.79 Mutual SMZ-TMP ... Free with registration - Chain Drug Review - AccessMyLibrary.com Merger and Acquisition Scenario - Apr 5, 2008 Buyer (Total: 272). Xolair (Omalizumab); Dilatrend (Carvedilol); Demadex (Torsemide); Bumex (Bumetanide). Target (Total: 251). 256066 (PDE IV Inhibitor) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 13, 2008 Buyer (Total: 272). Xolair (Omalizumab); Dilatrend (Carvedilol); Demadex (Torsemide); Bumex (Bumetanide). Target (Total: 231) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 16, 2008 Buyer (Total: 271). Xolair (Omalizumab); Dilatrend (Carvedilol); Demadex (Torsemide); Bumex (Bumetanide). Target (Total: 19). Plexion/Plexion TS/Plexion SCT ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 13, 2008 Buyer (Total: 272). Xolair (Omalizumab); Dilatrend (Carvedilol); Demadex (Torsemide); Bumex (Bumetanide). Target (Total: 64) ... $250.00 - Revere Reports - Revere Brand Names/Synonyms: Torsemide is also known by the following brand names and/or synonymsAC 4464; CCRIS 6736; Demadex; JDL 464; Luprac; TORSEMIDE; Torasemida [Inn-Spanish]; Torasemide; Torasemidum [Inn-Latin]; Torsemide; Torsemide [Usan] Drug Category: Torsemide is categorized under the following by the FDA: Diuretics; Antihypertensive Agents; ATC:C03CA01 Dosage Forms: LIQUID; TABLET Absorption: Rapidly absorbed. Bioavailability is 80% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 1-[4-(3-methylphenyl)aminopyridin-3-yl]sulfonyl-3-propan-2-yl-urea |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |